MedPath

Abbott Brady 3T MRI PMCF

Completed
Conditions
Presyncope
Syncope
Fatigue
Disorientation
Arrythmia
Bradycardia
Interventions
Radiation: 3T MRI scan
Registration Number
NCT03786640
Lead Sponsor
Abbott Medical Devices
Brief Summary

The objective of this post-market, clinical follow up (PMCF) study, is to confirm the long-term safety of the Tendril STS and Isoflex leads, implanted with the Assurity MRI™ or Endurity MRI™ pacemakers, in patients undergoing a clinically indicated 3T MRI (3 Tesla Magnetic Resonance Imaging) scan.

Detailed Description

This prospective, non-randomized, observational study will be conducted at 35 centers worldwide where the study devices have 3T MR Conditional labeling; up to 110 patients will be enrolled, and will satisfy the recent PMCF requirement to maintain the CE mark.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
3
Inclusion Criteria
  1. Subject must be willing and able to provide informed consent for study participation (legal guardian or legally authorized representative is NOT acceptable).
  2. Subject must be implanted with a St. Jude Medical Tendril STS 2088 or Isoflex 1944/1948 lead, and Assurity MRI or Endurity MRI pacemaker.
  3. Capture threshold is stable and < 2.5V @ 0.5ms at the time of enrollment.
  4. Subject is clinically indicated for a 3T MRI scan without sedation NOTE: Antianxiety agents (e.g. minor tranquilizers, etc.) may be used as long as the patient can communicate with site personnel during the MRI scan
  5. Subject is willing and able to comply with the prescribed follow-up tests and schedule of evaluations.
Exclusion Criteria
  1. The subject is currently participating in a clinical investigation that includes an active treatment arm that may confound the results of this study as determined by Abbott.
  2. The subject is <18 years old (pediatric).
  3. That subject has a life expectancy of less than 12 months due to any condition.
  4. Pregnant or nursing subjects and those who plan pregnancy during the clinical investigation follow-up period.
  5. Presence of other anatomic or comorbid conditions, or other medical, social, or psychological conditions that, in the investigator's opinion, could limit the subject's ability to participate in the clinical investigation or to comply with follow-up requirements, or impact the scientific soundness of the clinical investigation results.
  6. Any contraindication to MRI scan, including the presence of additional hardware (e.g. lead extenders, lead adapters, surgical staples, stents, dental braces, or abandoned leads).

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Single Arm3T MRI scanPatients implanted with an SJM Tendril STS 2088 or Isoflex 1944/1948 lead, together with an Assurity MRI or Endurity MRI pacemaker, and who will undergo a 3T MRI scan are eligible to participate in this study.
Primary Outcome Measures
NameTimeMethod
Proportion of subjects with a capture threshold increase of ≤ 0.5V at the permanently programmed pulse widthfrom pre- MRI scan to one-month post MRI scan
Secondary Outcome Measures
NameTimeMethod
Proportion of subjects with a sensing amplitude decrease of ≤ 50% from pre-MRI scan to one-month post-MRI scanfrom pre-MRI scan to one-month post-MRI scan

Trial Locations

Locations (9)

CHRU Hopital de Pontchaillou

🇫🇷

Rennes, Brittany, France

Hopital Cardiovasculaire et Pneumologique Louis Pradel

🇫🇷

Lyon, Rhone-alpes, France

Care Institute of Medical Sciences

🇮🇳

Ahmedabad, Gurarat, India

Eternal Haert Care Centre

🇮🇳

Jaipur, Rajasthan, India

Apollo Hospital

🇮🇳

Chennai, Tamil Nadu, India

Medisch Centrum Leeuwarden

🇳🇱

Leeuwarden, Friesland, Netherlands

Albert Schweiter Ziekenhuis

🇳🇱

Dordrecht, Zuid-Holland, Netherlands

Tartu University Hospital

🇪🇪

Tartu, Estonia

AOU Federico II - Università degli Studi di Napoli

🇮🇹

Napoli, Campania, Italy

© Copyright 2025. All Rights Reserved by MedPath